知镜 Cognispect · 医学文献与研究工作台

Serum Proteomic Profiling by SomaScan Aptamer Array Identifies Candidate Predictive and Monitoring Biomarkers of Distant Recurrence in Triple-Negative Breast Cancer.

Kim J, Tanaka S, Fosah E, Jinno C, Kim H, Prathifkumar T, Fukui Y, Kawanishi K, Kawashima M, Masuda N, Levy J, Fujii T, You S, Furuya H.
International journal of molecular sciences · 2026-10-13 · PMID 42941844

文献摘要

Triple-negative breast cancer (TNBC) lacks a blood-based biomarker for predicting or monitoring distant recurrence. We profiled 39 serum samples from 38 women (10 healthy controls; 12 non-recurrent [NR]; eight diagnosis-timepoint samples from patients who later recurred [DR-DIG]; nine recurrence-timepoint samples [DR-REC]) using the SomaScan v5.0 aptamer platform). Public tumor-tissue transcriptomic cohorts were used for supportive and exploratory analyses. No protein reached a false discovery rate (FDR) p = 0.018; HR = 0.186, p = 0.0057). Monitor genes showed near-chance concordance with metastatic tissue, and the source of the signature could not be resolved. An exploratory four-gene elastic-net panel reached a concordance index of 0.613 internally but 0.559 externally. GZMA is a candidate serum biomarker of TNBC recurrence risk, and the monitor signature is a preliminary observation. Both require protein-level validation in independent, prospectively collected serum cohorts.

在知镜精读原文来源DOI 原文

知镜提供医学文献检索、阅读笔记、人体图谱、统计绘图与研究复现工具。